The Potential of Connected Devices for Tackling Asthma

The Potential of Connected Devices for Tackling Asthma

23 Jun 2017

Including results from a clinical trial in asthmatics, comparing outcomes from smart inhaler use with standard inhaler control, Garth Sutherland, MSc, Founder & Executive Director of Adherium, and Jon-Paul Sherlock, PhD, Head of Respiratory Digital Health at AstraZeneca, explain how a strategic partnership between pharmaceutical companies and digital health companies can achieve improved outcomes through joint initiatives.

Read the full article here